JP2021532776A5 - - Google Patents
Info
- Publication number
- JP2021532776A5 JP2021532776A5 JP2021505315A JP2021505315A JP2021532776A5 JP 2021532776 A5 JP2021532776 A5 JP 2021532776A5 JP 2021505315 A JP2021505315 A JP 2021505315A JP 2021505315 A JP2021505315 A JP 2021505315A JP 2021532776 A5 JP2021532776 A5 JP 2021532776A5
- Authority
- JP
- Japan
- Prior art keywords
- poloxamer
- optionally
- pge2
- cells
- hematopoietic cells
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024218336A JP2025038075A (ja) | 2018-07-30 | 2024-12-13 | 造血細胞の遺伝子改変のための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862712146P | 2018-07-30 | 2018-07-30 | |
| US62/712,146 | 2018-07-30 | ||
| PCT/US2019/044237 WO2020028430A1 (en) | 2018-07-30 | 2019-07-30 | Methods for gene modification of hematopoietic cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024218336A Division JP2025038075A (ja) | 2018-07-30 | 2024-12-13 | 造血細胞の遺伝子改変のための方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021532776A JP2021532776A (ja) | 2021-12-02 |
| JP2021532776A5 true JP2021532776A5 (https=) | 2022-08-04 |
| JPWO2020028430A5 JPWO2020028430A5 (https=) | 2022-08-04 |
| JP7664829B2 JP7664829B2 (ja) | 2025-04-18 |
Family
ID=69232048
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021505315A Active JP7664829B2 (ja) | 2018-07-30 | 2019-07-30 | 造血細胞の遺伝子改変のための方法 |
| JP2024218336A Pending JP2025038075A (ja) | 2018-07-30 | 2024-12-13 | 造血細胞の遺伝子改変のための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024218336A Pending JP2025038075A (ja) | 2018-07-30 | 2024-12-13 | 造血細胞の遺伝子改変のための方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210290685A1 (https=) |
| EP (1) | EP3830248A4 (https=) |
| JP (2) | JP7664829B2 (https=) |
| KR (1) | KR20210046004A (https=) |
| CN (1) | CN112888777A (https=) |
| AU (1) | AU2019315438B2 (https=) |
| BR (1) | BR112021001757A2 (https=) |
| CA (1) | CA3106241A1 (https=) |
| IL (2) | IL280465B2 (https=) |
| MX (1) | MX2021001292A (https=) |
| SG (1) | SG11202100025QA (https=) |
| WO (1) | WO2020028430A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3021572A1 (en) | 2016-04-20 | 2017-10-26 | Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas | Compositions and methods for enhanced gene expression of pklr |
| EP3697452A4 (en) | 2017-10-16 | 2021-11-24 | Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, O.A., M.P. | LENTIVIRAL VECTORS FOR ADMINISTRATION OF PKLR TO TREAT PYRUVATE KINASE DEFECTS |
| BR112020020841A2 (pt) | 2018-04-11 | 2021-01-19 | Fundacion Para La Investigacion Biomedica Del Hospital Infantil Universitario Nino Jesus | Composições e métodos para transplante de célulastronco |
| CA3096293A1 (en) | 2018-04-27 | 2019-10-31 | Rocket Pharmaceuticals, Ltd. | Gene therapy for cns degeneration |
| CA3163572A1 (en) * | 2020-05-27 | 2021-12-02 | Oleksandr PASTUKHOV | Novel transduction enhancers and uses thereof |
| JP2023538519A (ja) | 2020-08-07 | 2023-09-08 | スペースクラフト セブン リミテッド ライアビリティ カンパニー | Ａａｖベクターを使用したプラコフィリン－２（ｐｋｐ２）遺伝子治療 |
| CN114763563B (zh) * | 2021-01-12 | 2024-04-30 | 深圳华大临床检验中心 | 一种提高慢病毒感染效率的方法 |
| JP2024518770A (ja) | 2021-04-26 | 2024-05-02 | ストーム バイオ インコーポレイテッド | ファンコニ貧血のための巨核球由来細胞外小胞に関する組成物及び方法 |
| WO2025106604A1 (en) * | 2023-11-14 | 2025-05-22 | The University Of North Carolina At Chapel Hill | Compositions and methods relating to antiviral therapeutics |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017139576A1 (en) * | 2016-02-12 | 2017-08-17 | Bluebird Bio, Inc. | Vcn enhancer compositions and methods of using the same |
| US20220323612A1 (en) * | 2016-06-13 | 2022-10-13 | Bluebird Bio, Inc. | Gene therapy of neuronal ceroid lipofuscinoses |
| CN110536966A (zh) * | 2016-09-08 | 2019-12-03 | 能源环境和技术研究中心O.A.,M.P. | 用于范可尼贫血患者的基因疗法 |
| KR20190089988A (ko) * | 2016-12-06 | 2019-07-31 | 블루버드 바이오, 인코포레이티드. | I형 점액다당류증에 대한 유전자 요법 |
| KR20190088554A (ko) * | 2016-12-06 | 2019-07-26 | 블루버드 바이오, 인코포레이티드. | Ii형 점액다당류증에 대한 유전자 요법 |
-
2019
- 2019-07-30 KR KR1020217005904A patent/KR20210046004A/ko active Pending
- 2019-07-30 IL IL280465A patent/IL280465B2/en unknown
- 2019-07-30 WO PCT/US2019/044237 patent/WO2020028430A1/en not_active Ceased
- 2019-07-30 JP JP2021505315A patent/JP7664829B2/ja active Active
- 2019-07-30 CN CN201980049019.6A patent/CN112888777A/zh active Pending
- 2019-07-30 IL IL316185A patent/IL316185A/en unknown
- 2019-07-30 EP EP19844952.2A patent/EP3830248A4/en active Pending
- 2019-07-30 US US17/264,275 patent/US20210290685A1/en active Pending
- 2019-07-30 BR BR112021001757-7A patent/BR112021001757A2/pt unknown
- 2019-07-30 SG SG11202100025QA patent/SG11202100025QA/en unknown
- 2019-07-30 MX MX2021001292A patent/MX2021001292A/es unknown
- 2019-07-30 CA CA3106241A patent/CA3106241A1/en active Pending
- 2019-07-30 AU AU2019315438A patent/AU2019315438B2/en active Active
-
2024
- 2024-12-13 JP JP2024218336A patent/JP2025038075A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021532776A5 (https=) | ||
| CN112040988A (zh) | 修饰的aav衣壳多肽用于治疗肌肉疾病 | |
| Chen et al. | Combined cord blood stem cells and gene therapy enhances angiogenesis and improves cardiac performance in mouse after acute myocardial infarction | |
| CN103263439B (zh) | Cd34干细胞相关方法和组合物 | |
| JP7048494B2 (ja) | 修飾ｔ細胞に対する条件的活性型キメラ抗原受容体 | |
| CN103687946B (zh) | 用于诱导组织再生的肽及其应用 | |
| E Adair et al. | Lessons learned from two decades of clinical trial experience in gene therapy for Fanconi anemia | |
| US20150139952A1 (en) | Methods, compositions, cells, and kits for treating ischemic injury | |
| HUE035043T2 (en) | A pharmaceutical composition for promoting functional regeneration of damaged tissue | |
| CN102076350A (zh) | 将骨髓来源的多能干细胞动员到末梢循环的药物 | |
| Bortolotti et al. | In vivo functional selection identifies cardiotrophin-1 as a cardiac engraftment factor for mesenchymal stromal cells | |
| JP2023138660A5 (https=) | ||
| IL285039B1 (en) | Compositions and methods for stimulating natural killer cells | |
| US20240139254A1 (en) | Mesenchymal stem cell having oxidative stress resistance, preparation method therefor, and use thereof | |
| WO2009139413A1 (ja) | サイトカイン誘導キラー細胞含有細胞集団の製造方法 | |
| CN115552019A (zh) | 在髓样细胞和小胶质细胞中特异性表达治疗性蛋白的病毒载体 | |
| WO2021168413A1 (en) | Basic domain-deleted dnase1-like 3 and uses thereof | |
| JPWO2020028430A5 (https=) | ||
| TWI881993B (zh) | Ｔ細胞受體及其使用方法 | |
| JP2020517289A5 (https=) | ||
| EP4711444A2 (en) | Endothelial cells for mitigation of chemotherapy-induced toxicity | |
| KR20220038776A (ko) | T 세포 수용체 및 이의 사용 방법 | |
| JP2025528163A (ja) | キメラｃｄ８－アルファ補助受容体組成物及び使用方法 | |
| JP2025506976A (ja) | 低免疫原性幹細胞、幹細胞から分化または由来した低免疫原性細胞およびこの製造方法 | |
| CN1926234A (zh) | 使用nm23的细胞培养,包含nm23的细胞培养基和在nm23存在下培养的细胞的治疗性用途 |